For Alzheimer’s Scientists, the Amyloid Debate Has No Easy Answers

For years, potential therapies that attack this brain protein have failed to help patients in clinical trials. Now—surprisingly—a new drug shows promise. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Episode metadata supplied by the publisher feed · Published Dec 1, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

For Alzheimer’s Scientists, the Amyloid Debate Has No Easy Answers

0:00 11:16

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Science, Spoken?

This episode is 11 minutes long.

When was this Science, Spoken episode published?

This episode was published on December 1, 2022.

Can I download this Science, Spoken episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!